Skip to main content
. 2017 Nov 10;96(45):e8534. doi: 10.1097/MD.0000000000008534

Figure 1.

Figure 1

Findings of contrast-enhanced computed tomography (CT). (A) CT before the treatment showing an 8 × 8-cm mass in the pancreatic tail and liver metastasis. (B) On CT taken 6 months after the initiation of chemotherapy with gemcitabine, the primary pancreatic tumor and liver metastases both appeared to be progressive. (C) On CT taken 12 months after the initiation of chemotherapy with S-1, size reductions were observed in the primary tumor and liver metastases.